eScholarship
metadata only
Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum
The target for the "rapid" (<24 h) antidepressant effects of S-ketamine is unknown, vitiating programs to rationally develop more effective rapid antidepressants. To describe a drug's target, one must first understand the compartments entered by the drug, at all levels-the organ, the cell, and th
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy#991835
- Ketamine in Severe Traumatic Brain Injury#914342
- SPECTRA-based Detection of Drug-Induced Hepatotoxicity through Extracellular Vesicle Analysis.#653357
- The mecillinam resistome in <i>Klebsiella pneumoniae</i> : how resistance to a one-target β-lactam triggers a diversity of responses#274313
- Determination of the practical utility of ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): mapping OncoKB level 1 alterations using ESCAT#290758
Record · ID 1174846
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive